Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes
Research
[키워드] 2003
229E
against SARS-CoV
antibody
coronavirus
coronavirus strain
correlated
cross-neutralization
determine
develop
emerging
handling
Hong Kong
human sera
Immunity
in vitro
Infectious diseases
long-lasting
microneutralization
natural infection
neutralization tests
Neutralizing antibodies
Neutralizing antibody response
Neutralizing titer
NO
OC43
occurred
outbreak
Profiling
pseudotype
recovered patients
Research
response
SARS patient
SARS virus
SARS-CoV
SARS-CoV neutralizing antibodies
SARS-CoV S
SARS-CoV spike protein
serum sample
Spike protein
Vaccines
was used
[DOI] 10.3201/eid1103.040906 PMC 바로가기 [Article Type] Research
[DOI] 10.3201/eid1103.040906 PMC 바로가기 [Article Type] Research